Product Information

LACOSAMIDE 50 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.1153 per EA under NDC 69367034860. Its NADAC has been published 159 times since Aug 9, 2023.

FDA first approved this application on Mar 17, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LACOSAMIDE 50 MG TABLET

Lacosamide
$0.1153per EA
DEA Schedule CV

Strength

50 mg/1

NDC

69367034860

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LACOSAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205237

FDA Approved

3/17/2022

TE Code

AB

On Market Since

7/10/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for LACOSAMIDE 50 MG TABLET has been published 159 times since Aug 9, 2023, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1153 per EA
All-time high$0.1962 (Mar 13, 2024)
All-time low$0.1045 (Nov 20, 2024)
52-week high$0.1359
52-week low$0.1046
Median price$0.1410
Average price$0.1470
Largest weekly change+38.3% (Aug 21, 2024)
Weeks tracked159
Tracking sinceAug 9, 2023

Price History

1W

+3.4%

1M

+3.4%

3M

+8.7%

6M

+2.0%

1Y

-15.2%

3Y

-40.6%

5Y

N/A

All

-40.6%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LACOSAMIDE 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 50 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.1153 per EA (NDC 69367034860), effective Aug 19, 2026.

How has the price of LACOSAMIDE 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for LACOSAMIDE 50 MG TABLET has declined 40.6%. It has been tracked across 159 weekly CMS publications since Aug 9, 2023.

What are the highest and lowest recorded NADAC prices for LACOSAMIDE 50 MG TABLET?

Since Aug 9, 2023, the NADAC for LACOSAMIDE 50 MG TABLET has ranged from a low of $0.1045 (Nov 20, 2024) to a high of $0.1962 (Mar 13, 2024), with a median of $0.1410 per EA.

Are there cheaper alternatives to LACOSAMIDE 50 MG TABLET?

Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 50 MG TABLET, is $0.1061 per EA — about 8% below LACOSAMIDE 50 MG TABLET.

Who manufactures LACOSAMIDE 50 MG TABLET?

LACOSAMIDE 50 MG TABLET (NDC 69367034860) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.